
Sudo Bio
Sudo Biosciences develops first- and best-in-class medicines for serious neurological and immunological conditions like multiple sclerosis (MS) and other immune-mediated inflammatory conditions.
$37M Series A ·
Source: fundraisingfox.com
Funding history ↓Signals
Website registeredMar 25, 2020 (6 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $37M | — | fundraisingfox.com |
Timeline
- Website created
Companies like Sudo Bio
MMirador Therapeutics$250M Series B+ · Jan 2026
EEccogene$25.2M Series B+ · Jun 2023BBionyra$165M Series A · Jun 2026
CCitryll$92.5M Series B+ · Dec 2024
MMemo Therapeutics$22M Series B+ · May 2024HHI-Bio$95M Series B+ · Jan 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/sudo-bio (get a free API key).